期刊信息/Journal information
：中山大学肿瘤防治中心
：徐瑞华
：月刊
：1000-467X
：44-1195/R
：aizh@cjcsysu.cn
：020-87343064
：510060
：广州中山大学肿瘤防治中心编辑部
癌症/Journal Chinese Journal of Cancer北大核心CSCDCSTPCDSCI
《癌症》从1992年起，首批进入中国科技核心期刊，是中国科学引文数据库来源期刊，中国学术期刊综合评价数据库来源期刊和中国学术期刊（光盘版）全文收录期刊。被收录入MEDLINE期刊。
收录年代
Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers
Kadri Altundag282-283
Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
Dong Wang;Ruikai Du;Suling Liu245-246
The 150 most important questions in cancer research and clinical oncology series:questions 31-39
Chinese Journal of Cancer247-251
Immunological effect of local ablationcombined with immunotherapy on solidmalignancies
Yusuke Takahashi;Noriyuki Matsutani;Takashi Nakayama;Hitoshi Dejima;Hirofumi Uehara;Masafumi Kawamura252-257
CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China
Yanfen Feng;Huilan Rao;Yiyan Lei;Yuhua Huang;Fang Wang;Yu Zhang;Shaoyan Xi;Qiuliang Wu;Jianyong Shao258-266
Association between DNA mismatch repair gene polymorphisms and platinum-based chemotherapy toxicity in non-small cell lung cancer patients
Jun‑Yan Liu;Chen‑Yue Qian;Yuan‑Feng Gao;Juan Chen;Hong‑Hao Zhou;Ji‑Ye Yin267-273
Weekly taxane–anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer: a randomized controlled trial
Qiu‑Wen Tan;Ting Luo;Hong Zheng;Ting‑Lun Tian;Ping He;Jie Chen;He‑Lin Zeng;Qing Lv274-281